Epigallocatechin-3-gallate inhibits growth and induces apoptosis in esophageal cancer cells through the demethylation and reactivation of the p16 gene
Authors:
- 25 May 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 1152-1156
Abstract
The present study aimed to investigate the effect of treatment with epigallocatechin-3-gallate (EGCG) on the human esophageal cancer cell line ECa109 and elucidate the associated underlying mechanisms. ECa109 cells were cultured and treated with increasing concentrations of EGCG for various durations. Cell viability was evaluated using the MTT assay and apoptosis was detected using flow cytometry. The methylation status of the cyclin‑dependent kinase inhibitor 2A (p16) gene was analyzed using the methylation‑specific polymerase chain reaction (PCR). p16 mRNA and protein expression was measured using reverse transcription‑quantitative PCR and western blot analysis, respectively. The results of the present study demonstrated that, following treatment with EGCG, ECa109 cell viability was significantly decreased, while the rate of apoptosis was significantly increased (P<0.01), in a dose‑ and time‑dependent manner. Following treatment of ECa109 cells with EGCG, p16 gene demethylation, and its mRNA and protein expression, were significantly increased compared with the untreated cells (P<0.01). EGCG may induce ECa109 cell apoptosis and inhibit cell growth through p16 gene demethylation, which restores its expression.Keywords
This publication has 25 references indexed in Scilit:
- Green Tea Polyphenol Epigallocatechin-3-gallate–Alleviated Coxsackievirus B3–induced Myocarditis Through Inhibiting Viral Replication but Not Through Inhibiting Inflammatory ResponsesJournal of Cardiovascular Pharmacology, 2017
- Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea CatechinsMolecules, 2016
- Early esophageal cancer screening in ChinaBest Practice & Research Clinical Gastroenterology, 2015
- Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyOncotarget, 2014
- Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damageFood and Chemical Toxicology, 2013
- The role of paclitaxel in the development and treatment of multidrug resistant cancer cell linesBiomedicine & Pharmacotherapy, 2011
- Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinasesMolecular Nutrition & Food Research, 2011
- ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapyLife Sciences, 2010
- Effects of Tea Consumption on Nutrition and HealthThe Journal of Nutrition, 2000
- The chemistry of tea flavonoidsCritical Reviews in Food Science and Nutrition, 1997